Cargando…

Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast

BACKGROUND: In this study, we investigated CD20+ TILs in triple-negative breast cancer (TNBC) and their relationship with T lymphocyte subsets (CD4+, CD8+, CD25+, and FOXP3+), including their combined prognostic value using an immunohistochemical staining method. METHODS: We investigated 107 patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuroda, Hajime, Jamiyan, Tsengelmaa, Yamaguchi, Rin, Kakumoto, Akinari, Abe, Akihito, Harada, Oi, Masunaga, Atsuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968181/ https://www.ncbi.nlm.nih.gov/pubmed/33726701 http://dx.doi.org/10.1186/s12885-021-08009-x

Ejemplares similares

Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
por: Kuroda, Hajime, et al.
Publicado: (2021)

Gastric Adenocarcinoma of the Fundic Gland Type: A Case Report
por: Kakumoto, Akinari, et al.
Publicado: (2021)

CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes
por: Kuroda, H., et al.
Publicado: (2021)

Primary Hepatic Angioleiomyoma: A Case Report
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2023)

Characteristic Histological Findings of Asymptomatic EBV-associated Lymphoproliferative Disorders in Tonsils
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2018)

Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining
por: Kuroda, Hajime, et al.
Publicado: (2018)

The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2017)

Plasmacytoid urothelial carcinoma of renal pelvis with positive zinc finger E–box–binding homeobox 1: a case report
por: Takada-Owada, Atsuko, et al.
Publicado: (2020)

Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma
por: Kamai, Takao, et al.
Publicado: (2021)

Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers
por: Lv, Yufei, et al.
Publicado: (2021)

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis
por: TAKENAKA, MIKI, et al.
Publicado: (2013)

Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
por: Boissière-Michot, Florence, et al.
Publicado: (2021)

CXCR2 Levels Correlate with Immune Infiltration and a Better Prognosis of Triple-Negative Breast Cancers
por: Boissière-Michot, Florence, et al.
Publicado: (2021)

Association of CD206 Protein Expression with Immune Infiltration and Prognosis in Patients with Triple-Negative Breast Cancer
por: Bobrie, Angélique, et al.
Publicado: (2022)

HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration
por: Ying, Bicheng, et al.
Publicado: (2022)

Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer
por: Huertas-Caro, Carlos A., et al.
Publicado: (2023)

Sphingosine-1-Phosphate Catabolizing Enzymes Predict Better Prognosis in Triple-Negative Breast Cancer Patients and Correlates With Tumor-Infiltrating Immune Cells
por: Nema, Rajeev, et al.
Publicado: (2021)

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
por: Harano, Kenichi, et al.
Publicado: (2018)

Survivin Selectively Modulates Genes Deregulated in Human Leukemia Stem Cells
por: Fukuda, Seiji, et al.
Publicado: (2011)

Tumor-infiltrating lymphocytes and CD8(+) T cells predict survival of triple-negative breast cancer
por: Vihervuori, H., et al.
Publicado: (2019)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
por: Quintana, Ángela, et al.
Publicado: (2023)

Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients
por: Boucher, Yves, et al.
Publicado: (2021)

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
por: Li, Huihui, et al.
Publicado: (2023)

Immune Cell Infiltrate and Prognosis in Gastric Cancer
por: Kemi, Niko, et al.
Publicado: (2020)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer
por: Wang, Xiaoyu, et al.
Publicado: (2021)

Comprehensive genomic and immunophenotypic analysis of CD4 T cell infiltrating human triple-negative breast cancer
por: Zhang, He, et al.
Publicado: (2020)

3D Collagen Fiber Concentration Regulates Treg Cell Infiltration in Triple Negative Breast Cancer
por: Gao, Huan, et al.
Publicado: (2022)

FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts
por: Wu, Yushen, et al.
Publicado: (2022)

The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
por: Li, Ruonan, et al.
Publicado: (2023)

Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer
por: Čeprnja, Toni, et al.
Publicado: (2022)

Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management
por: Gorenšek, Rok, et al.
Publicado: (2023)

Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis
por: He, Ting-Fang, et al.
Publicado: (2020)

Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21(Cdkn1a) and Pbx1 in Hematopoietic Cells
por: Abe, Mariko, et al.
Publicado: (2016)

B cell infiltration is highly associated with prognosis and an immune-infiltrated tumor microenvironment in neuroblastoma
por: Schaafsma, Evelien, et al.
Publicado: (2021)

Novel therapy for locally advanced triple-negative breast cancer
por: YAMADA, ATSUKO, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f0lr8il2hbknmsu1ic3b6b79ba